[Extracorporeal membrane oxygenation (ECMO). A treatment alternative for newborn infants with severe respiratory disorder].
Extracorporeal Membrane Oxygenation (ECMO) is a promising alternative for newborns with critical respiratory disease, where conservative management is no longer sufficient. - Indications for ECMO include mainly the diagnoses Persisting Pulmonary Hypertension (PPHN), Meconium-Aspiration and Congenital Diaphragmatic Hernia. In patients with a mortality-prognosis of 80-100% ECMO will raise survival rates to about 80% with a good general developmental prognosis. Conditions, trainee programs, and experiences up to the first clinical application of ECMO are reported.
Kachel
W
W
Universitäts-Kinderklinik, Mannheim.
Arnold
D
D
Rettwitz
W
W
Lasch
P
P
Brands
W
W
D004200:Diseases in Twins; D005112:Extracorporeal Circulation / Q000295:instrumentation*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010100:Oxygen / Q000097:blood; D010107:Oxygenators, Membrane; D011379:Prognosis; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*
D010100:Oxygen
Extrakorporale Membranoxygenisierung (ECMO). Eine Behandlungsalternative für Neugeborene mit schwerer Atemstörung.